Silver-Doped Hydroxyapatite Thin Layers Obtained by Sol-Gel Spin Coating Procedure
Source abstract
Abstract
The main objective of this paper is to develop silver-doped hydroxyapatite suspensions (HApAg) with different concentrations of silver (xAg = 0.05 and xAg = 0.2) in order to obtain uniform and homogenous layers by spin-coating procedure. The colloidal properties of HApAg suspensions are evaluated by dynamic light scattering (DLS) analysis, ζ-potential (ZP), and ultrasound measurements. The ultrasound studies show that the HApAg20 sample revealed better stability than the HApAg5 sample. The structural and morphological analysis on suspensions and thin layers is also conducted. It is observed that the particles of the two samples have a similar shape and are uniform. The layers obtained present a homogeneous appearance of the surface without evidence of cracks or interruption of the coatings. The in vitro antifungal studies conducted on the two thin layers at two different time intervals (24 and 48 h) show that both HApAg5 (xAg = 0.05) and HApAg20 (xAg = 0.05) nanoparticles suspensions and composite layers inhibit the development of colony forming units (CFU) even after 24 h of incubation comparative to the control, represented by the Candida albicans (C. albicans) culture in a proper medium. The fungicidal effect was evident after 48 h of incubation in the case of both HApAg20 nanoparticles suspensions and composite layers.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticles: synthesis and applications · Laser-Ablation Synthesis of Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari, Sector 5, 050474 Bucharest, Romania
Emergency Hospital Floreasca Bucharest, 8 Calea Floresca, 014461 Bucharest, Romania
National Institute of Materials Physics, Atomistilor Street, No. 405A, P.O. Box MG 07, 077125 Magurele, Romania
University Politehnica of Bucharest, BN 002, 313 Splaiul Independentei, Sector 6, 060042 Bucharest, Romania
ISTO, UMR 7327 CNRS Université d’Orléans, 1A rue de la Férollerie, 45071 Orléans CEDEX 2, France
Funding
Romanian Ministry of Research and Innovation
References (44)
Show source-provided references
1. Preparation and characterization of nanosilver-doped porous hydroxyapatite scaffolds10.1016/j.ceramint.2014.09.108 ↗
2. Functionally graded hydroxyapatite coatings doped with antibacterial components10.1016/j.actbio.2009.12.002 ↗
3. Silver nanoparticles as a new generation of antimicrobials10.1016/j.biotechadv.2008.09.002 ↗
4. A prospective material for orthopedic applications: Ti substrates coated with a composite coating of a titania-nanotubes layer and a silver-manganesedoped hydroxyapatite layer10.1016/j.ceramint.2017.12.197 ↗
5. Incorporation of silver nanoparticles into magnetron-sputtered calcium phosphate layers on titanium as an antibacterial coating10.1016/j.colsurfb.2017.05.016 ↗
6. Acidic extracellular microenvironment and cancer10.1186/1475-2867-13-89 ↗
7. Berzina-Cimdina, L. Functionalized silver doped hydroxyapatite scaffolds for controlled simultaneous silver ion and drug delivery10.1016/j.ceramint.2016.11.214 ↗
8. Calcium phosphate porous pellets as drug delivery systems: Effect of drug carrier composition on drug loading and in vitro release10.1016/j.jeurceramsoc.2012.01.018 ↗
9. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections10.1016/j.biomaterials.2004.06.045 ↗
10. Biofilm Formation in Medical Device-Related Infection10.1177/039139880602900404 ↗
11. Bisno, A.L., and Waldvogel, F.A. (1994). Host factors predisposing to and influencing therapy of foreign body infections. Infections Associated with Indwelling Medical Devices, ASM Press.
12. Bisno, A.L., and Waldvogel, F.A. (1994). Prothetic joint infections. Infections Associated with Indwelling Medical Devices, ASM Press.
13. Bioactive delivery systems for the slow-release of antibiotics—Incorporation of Ag+ ions into micro-porous hydroxyapatite coatings10.1016/0167-577X(95)00059-3 ↗
14. Williams, D.W., Jordan, R.P., Wei, X.Q., Alves, C.T., Wise, M.P., Wilson, M.J., and Lewis, M.A. (2013). Interactions of Candida albicans with host epithelial surfaces. J. Oral Microbiol., 5.10.3402/jom.v5i0.22434 ↗
15. Hydroxyapatite–silver nanoparticles coatings on porous polyurethane scaffold10.1016/j.msec.2013.10.024 ↗
16. The significance of infection related to orthopedic devices and issues of antibiotic resistance10.1016/j.biomaterials.2005.11.044 ↗
17. Synthesis of silver-incorporated hydroxyapatite nanocomposites for antimicrobial implant coatings10.1016/j.apsusc.2013.02.130 ↗
18. Structural properties of silver doped hydroxyapatite and their biocompatibility10.1016/j.msec.2012.12.042 ↗
19. Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering10.1016/j.apsusc.2010.12.113 ↗
20. Fabrication, characterization, and antimicrobial activity, evaluation of low silver concentrations in silver-doped hydroxyapatite nanoparticles10.1155/2013/194854 ↗
21. Iconaru, S.L., Chapon, P., Le Coustumer, P., and Predoi, D. (2014). Antimicrobial activity of thin solid films of silver doped hydroxyapatite prepared by sol-gel method. Sci. World J., 2014.10.1155/2014/165351 ↗
22. Predoi, D., Iconaru, S.L., and Predoi, M.V. (2018). Bioceramic Layers with Antifungal Properties. Coatings, 8.10.3390/coatings8080276 ↗
23. Glocker, D.A., and Ranade, S.V. (2016). Biocompatibility and Medical Device Coatings. Medical Coatings and Deposition Technologies, John Wiley & Sons.10.1002/9781119308713 ↗
24. In vitro biocompatibility and antimicrobial activity of wet chemically prepared Ca10−xAgx(PO4)6(OH)2 (0.0 ≤ x ≤ 0.5) hydroxyapatites10.1016/j.msec.2011.04.015 ↗
25. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization10.1002/jbm.a.30958 ↗
26. Structural and physical properties of antibacterial Ag-doped nano-hydroxyapatite synthesized at 100 °C10.1186/1556-276X-6-613 ↗
27. (2018, January 10). ImageJ Website, Available online: http://imagej.nih.gov/ij.
28. Iconaru, S.L., Prodan, A.M., Turculet, C.S., Beuran, M., Ghita, R.V., Costescu, A., Groza, A., Chifiriuc, M.C., Chapon, P., and Gaiaschi, S. (2016). Enamel Based Composite Layers Deposited on Titanium Substrate with Antifungal Activity. J. Spectrosc., 2016.10.1155/2016/4361051 ↗
29. ASTM International (2013). ASTM E2149–13a Standard Test Method for Determining the Antimicrobial Activity of Antimicrobial Agents under Dynamic Contact Conditions, ASTM International.
30. Bioinspired phosphorylcholine containing polymer films with silver nanoparticles combining antifouling and antibacterial properties10.1039/c2bm00155a ↗
31. Predoi, D., Iconaru, S.L., Predoi, M.V., Buton, N., and Motelica-Heino, M. (2019). Zinc Doped Hydroxyapatite Thin Films Prepared by Sol–Gel Spin Coating Procedure. Coatings, 9.10.3390/coatings9030156 ↗
32. Klug, H.P., and Alexander, L.E. (1974). X-ray Diffraction Procedures for Polycrystallite and Amorphous Materials, Wiley. [2nd ed.].
33. Barrett, C.S., Cohen, J.B., Faber, J., Jenkins, R., Leyden, D.E., Russ, J.C., and Predecki, P.K. (1986). Advances in X-ray Analysis, Plenum Press.10.1007/978-1-4613-1935-1 ↗
34. Sipsasa, N.V., and Kontoyiannis, D.P. (2012). Invasive fungal infections in patients with cancer in the intensive care unit. Int. J. Antimicrob. Agents, 39.10.1016/j.ijantimicag.2011.11.017 ↗
35. Risk factors for albicans and non-albicans candidemia in the intensive care unit10.1097/CCM.0b013e31816fc4cd ↗
36. Predoi, D., Iconaru, S.L., Predoi, M.V., Stan, G.E., and Buton, N. (2019). Synthesis, Characterization, and Antimicrobial Activity of Magnesium-Doped Hydroxyapatite Suspensions. Nanomaterials, 9.10.3390/nano9091295 ↗
37. Predoi, D., Iconaru, S.L., Predoi, M.V., Motelica-Heino, M., Guegan, R., and Buton, N. (2019). Evaluation of Antibacterial Activity of Zinc-Doped Hydroxyapatite Colloids and Dispersion Stability Using Ultrasounds. Nanomaterials, 9.10.3390/nano9040515 ↗
38. Ceramic/metal biocidal nanocomposites for bone-related applications
39. Antifungal susceptibility of Candida albicans in biofilms10.1111/j.1439-0507.2011.02076.x ↗
40. Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implants10.1111/j.1439-0507.1999.tb00021.x ↗
41. Candida biofilms on implanted biomaterials: A clinically significant problem10.1111/j.1567-1364.2006.00117.x ↗
42. Ciobanu, C.S., Groza, A., Iconaru, S.L., Popa, C.L., Chapon, P., Chifiriuc, M.C., Hristu, R., Stanciu, G.A., Negrila, C.C., and Ghita, R.V. (2015). Antimicrobial activity evaluation on silver doped hydroxyapatite/polydimethylsiloxane composite layer. BioMed Res. Int., 2015.10.1155/2015/926513 ↗
43. Groza, A., Ciobanu, C.S., Popa, C.L., Iconaru, S.L., Chapon, P., Luculescu, C., Ganciu, M., and Predoi, D. (2016). Structural Properties and Antifungal Activity against Candida albicans Biofilm of Different Composite Layers Based on Ag/Zn Doped Hydroxyapatite-Polydimethylsiloxanes. Polymers, 8.10.3390/polym8040131 ↗
44. Structural and Antimicrobial Evaluation of Silver Doped Hydroxyapatite-Polydimethylsiloxane Thin Layers10.1155/2017/7492515 ↗